MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: dystonia"

  • 2025 International Congress

    Pilot Study: Shear Wave Elastography as a Potential Biomarker in Task-Specific Dystonia

    A. Ly, A. Mushtaheed, A. Roberts, M. Druckenbrod, J. Stowers, M. Soliman, P. Lind, Y. Assefa, C. Stanley, A. Gravunder, J. Matsubara, C. Zampieri-Gallagher, D. Ehrlich, B. Karp, F. Gavelli, K. Alter (Bethesda, USA)

    Objective: The purpose of this study was to explore shear wave elastography (SWE)’s ability to identify task-specific dystonic muscles by determining if muscle stiffness increased…
  • 2025 International Congress

    Comparative Effectiveness of Botulinum Toxin vs. Oral Medications in the Management of Cervical Dystonia: A Multi-Center Study

    A. Chandra, A. Chandra, S. Acharya (Tianjin, China)

    Objective: This study aims to compare the effectiveness of botulinum toxin injections versus oral medications in the symptomatic management of cervical dystonia , evaluating their…
  • 2025 International Congress

    Physician Assessment of Non-Medical Toxin Switching on Patient Care

    P. Charles, L. Venditti, M. Nelson, R. Singh, K. Pazira, H. Kling, L. Kopaeva, S. Sharp, K. Harper (Nashville, USA)

    Objective: To gain an understanding from physicians on the impact of non-medical toxin switching (NMTS) in the treatment of movement disorders and other chronic conditions…
  • 2025 International Congress

    Patient Perspectives on the Therapeutic Effects of Botulinum Toxin in Cervical Dystonia

    M. Relja, D. Dressler, F. Morgante, V. Trjulja (Zagreb, Croatia)

    Objective: To investigate patient perspectives on the therapeutic effects of botulinum toxin type-A  (BoNT-A) in cervical dystonia (CD) using patient s on-line survey. Background: CD…
  • 2024 International Congress

    Efficacy Remaining at Time of Requested Retreatment Following Botulinum Toxin Treatment for Cervical Dystonia: Potential for a New Treatment Paradigm with DaxibotulinumtoxinA

    A. Ellenbogen, R. Hauser, A. Patel, P. Mcallister, D. Vitarella, T. Gross, R. Kazerooni, C. Gallagher, D. Hollander (Farmington Hills, USA)

    Objective: To assess the residual therapeutic efficacy of prior botulinum toxin (BoNT) injection at the patient-desired retreatment interval in cervical dystonia (CD). Background: BoNT injections…
  • 2024 International Congress

    Efficacy and Safety of DaxibotulinumtoxinA-lanm for Injection in Adults with Cervical Dystonia: Pooled Global Analysis of ASPEN-1 and ASPEN-1-CN

    D. Truong, H. Xingyue, A. Ellenbogen, J. Lingjing, K. Dashtipour, A. Patel, T. Gross, R. Kazerooni, C. Gallagher, F. Xiaojin, S. Yunan, G. Lei, W. Xinhua, D. Hollander (Riverside, USA)

    Objective: To evaluate the pooled efficacy and safety of 2 doses of DaxibotulinumtoxinA-lanm for injection (DAXI) for the treatment of cervical dystonia (CD) in 2…
  • 2024 International Congress

    Effect Of Botulinum Toxin On Non-Motor Symptoms In Adult-Onset Idiopathic Focal Dystonia

    S. Mehta, R. Gupta, N. Balaini, S. Grover, V. Lal (Chandigarh, India)

    Objective: To assess the effect of Botulinum toxin on non-motor symptoms and quality of life in patients with adult-onset idiopathic focal dystonia. Background: A broad…
  • 2024 International Congress

    Real-World Diagnosis of Chronic Migraine in Patients With Cervical Dystonia Analyzed by Botulinum Neurotoxin Treatment Exposure: an Epidemiologic Perspective

    R. Rodriguez, S. Broner, G. Forde, C. Rhyne, M. Sadeghi, E. Yue, A. Ukah, K. Becker Ifantides, H. Sarva (Orlando, USA)

    Objective: Describe the real-world diagnosis, demographics, and clinical characteristics of chronic migraine (CM) in cervical dystonia (CD) patients stratified by botulinum neurotoxin (BoNT) treatment. Background:…
  • 2024 International Congress

    Comparison in Therapeutic Outcome of Ultrasound-Guided Botulinum Injections for Limb Spasticity Versus Dystonia

    G. Yahalom, M. Cohen, I. Israel, R. Eichel, Y. Schechter (Jerusalem, Israel)

    Objective: To compare the therapeutic efficacy of BT injections for spasticity and dystonia in the limbs. Background: Botulinum toxin (BT) shows promise in alleviating limb…
  • 2024 International Congress

    Real-World Retrospective Safety Analysis in Patients Treated With OnabotulinumtoxinA for Multiple Therapeutic Indications Over Repeat Treatment Periods

    G. Forde, A. Patel, K. Martinez, A. Mayadev, B. Brucker, T. Brown, Z. Ayyoub, R. Singh, M. Nelson, A. Ukah, I. Yushmanova, S. Battucci, K. Becker Ifantides, C. Rhyne (New Hyde Park, USA)

    Objective: To evaluate the real-world safety of onabotulinumtoxinA (onabotA) use over repeat treatment periods (TPs) in patients (pts) with concomitant multiple therapeutic indications. Background: In…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 21
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley